Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Thanks Beartrap
Appreciate the work that went into this post.
Best
Thank you for that link, Eagle8
Great informative read!
Prayers on the way
I believe this is current: Sentinus was acquired by Rothschild in 2023
https://www.sentinus.com/news/sentinus-rothschild/
Roman.......
Thanks for sharing that info
original link won't copy for update on law case
so
Google the following:
Twitter NWBO Hoffman
for Hoffman's synopsis of MTD from defendants
Skitahoe....
I join all the well wishers on the board in praying for your well being and your swift recovery
Karim Khoury, VP Information Systems (AmplifyBio) may have moved over to NWBO - I haven't come across it officially, (going backwards) for Mr Khoury's career.......NWBO ?? < AmplifyBio < Cognate BioServices < Toucan Capital
There have been a number of posts highlighting the beginning of AmplifyBio, a spinoff of Battelle Memorial. Some team members (Ganjei, Khoury, Yoon) from Cognate Bio were recruited to head the operation of this spinoff in May 2021. The linked post below was in answer to an environment question from a poster but some AmplifyBio info is included in that post.
AmplifyBio/Battelle/Cognate(Ganjei)/Toucan mention:
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=171841413
Current team at AmplifyBio:
https://www.amplify-bio.com/our-team/
Dr. Mark Lowdell is a highly respected advisor/consultant in the ATMP field and this recent award is testimony to that respect. You may refer to the acknowledgement page of the link I provided to note he was involved.
Best
Dr. Mark Lowdell CSO, INmune Bio receives The ISCT Career Achievement Award in Cell and Gene Therapy
https://www.inmunebio.com/index.php/newsroom/2024-news/muneioandoounderarkowdellheceives20240313050501
Dr. Mark Lowdell, Royal Free Hospital (acknowledgement in the following)
DCVax®-L: Mechanism of Action, Immunological Effects, and Clinical Trial External Controls Methodology
https://nwbio.com/wp-content/uploads/NWBT_ASCO_slides_06032023_FINAL.pdf
Prayers on the way
Knowing many of NWBO posters also follow INmune Bio, today’s PR just issued:
https://www.globenewswire.com/news-release/2024/03/05/2840360/0/en/INmune-Bio-Reports-Significant-EEG-Improvement-in-Alzheimer-s-Patients-Treated-with-XPro.html
I don’t think the poor chap realized that he hit a hornet’s nest with that stunt. I think he lives on Long Island; they love the British accent.
Pretty cheeky, that one!
New position listed at Advent BioServices:
Head of Production
“Job Summary
The Head of Production will be pivotal in leading the manufacturing operations, driving operational efficiency, and developing the Production Department into a new era of excellence. In collaboration with the Production Manager, this role will be responsible for developing a highly skilled team, guaranteeing optimal quality and safety, and ease new products into clinical production, working closely with internal and external stakeholders.”
https://adventbio.peoplehr.net/Pages/JobBoard/Opening.aspx?v=da864897-4a81-4df8-ae67-ef99bdda6378
Thank you, Antihama, for your added insight.
Best
Worth a read………….. (apologies if this has already been posted)
The Vital Importance of Working in Partnership with Other Regulators – An Interview with MHRA’s CEO Dr. June Raine - 2/20/24
https://www.fda.gov/international-programs/global-perspective/vital-importance-working-partnership-other-regulators-interview-mhras-ceo-dr-june-raine
“That's the scene setting. Where are we now? We've launched our International Recognition Procedure with seven reference regulators, and it's beginning to grow as of the beginning of January this year. There are two pathways: one is a straightforward, 60-day pathway with regulators where there are few differences between our standards and theirs, and a second where the applicant may have made some changes to the original dossier, which takes longer, at 110 days. So, watch this space.”
Thank you. Wishes accepted.
To my fellow posters who are engaging in the Navid Malik sub-story: Is this the same Mr. Malik of NWBO current controversy?
https://thelifesciencesdivision.com/about/our-team/
“Dr Malik headed up a number of smaller mid-cap broking firm healthcare franchises where he focused on marketing deals before co-founding The Life Sciences Division.”